Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: A secondary analysis of a randomized, double-blind, placebo-controlled trial

Authors

Brooks D Cash, University of South Alabama
Mark Pimentel, Cedars-Sinai Medical Center
Satish S C Rao, University of South Alabama
Leonard Weinstock, Washington University School of Medicine in St. Louis
Lin Chang, UCLA
Zeev Heimanson, Salix Pharmaceuticals
Anthony Lembo, Beth Israel Deaconess Medical Center

Journal

Therapeutic Advances in Gastroenterology

Publication Date

9-1-2017

Volume

10

Issue

9

First Page

689

Last Page

699

Document Type

Open Access Publication

DOI

10.1177/1756283X17726087

Rights and Permissions

Cash BD, Pimentel M, Rao SSC, Weinstock L, Chang L, Heimanson Z, Lembo A. Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial. Therap Adv Gastroenterol. 2017 Sep;10(9):689-699. doi: 10.1177/1756283X17726087. © The Author(s), 2017 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

Recommended Citation

Cash, Brooks D; Pimentel, Mark; Rao, Satish S C; Weinstock, Leonard; Chang, Lin; Heimanson, Zeev; and Lembo, Anthony, "Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: A secondary analysis of a randomized, double-blind, placebo-controlled trial." Therapeutic Advances in Gastroenterology. 10, 9. 689 - 699. (2017).
https://digitalcommons.wustl.edu/oa_3/11